Beyond Air Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors
Go back to Beyond Air Announces Positive Preclinical Data Supporting High Concentration Nitric Oxide as a Potential Treatment for Solid Tumors| (NASDAQ: XAIR) | Delayed: 0.41 +0.05 (13.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.36 | 52 Week High | $ | |||
| Open | $0.36 | 52 Week Low | $ | |||
| Day High | $0.41 | P/E | N/A | |||
| Day Low | $0.37 | EPS | $ | |||
| Volume | 299,109 | |||||

